Contrast

Contact

Share

MyChart

Help

Rauh named chairman of L+M boards

Monday, December 11, 2017

New London, CT (Dec. 11, 2017) – B. Michael Rauh, president and chief executive officer of Chelsea Groton Bank, was recently named chairman of the board of directors of L+M Healthcare and Lawrence + Memorial Hospital. Rauh, who began his role in October, succeeds R. Alan Hunter.

Rauh has been part of the L+M Hospital board since 2011 and the L+M Healthcare board since 2014.

“We are fortunate to have a leader like Michael Rauh as our chairman,” said Patrick L. Green, president and CEO of L+M Healthcare. “Michael has been an integral part of our board, helping to guide us through our affiliation with Yale New Haven Health. I look forward to partnering with him as we define the future of L+M Healthcare by transforming the organization and to further improve the health of our community.”

“Lawrence + Memorial Hospital is vital to our region,” Rauh said. “I’m excited for this opportunity, particularly as we continue to enjoy the benefits of our affiliation with Yale New Haven Health. In just one year, we have seen a substantial financial turnaround and stability, as well as an increase in access to care in our community.”

Lawrence + Memorial Hospital, a member of Yale New Haven Health, is a non-profit, 280-bed general and acute care hospital providing patient care to medical, surgical, pediatric, psychiatric and obstetrical patients in southeastern Connecticut and southern Rhode Island since 1912. Lawrence + Memorial offers cardiac acute, step-down and rehabilitation programs and is the only eastern Connecticut hospital that performs emergency and elective angioplasty. www.lmhospital.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.

Media Contact

Fiona Phelan

203-780-1993
860-271-4634

[email protected]